2 In an interview, Dillon, professor of internal medicine (endocrinology and metabolism) at Carver College of Medicine at the University of Iowa, talked to Targeted Oncology about considerations and potential risks of GLP-1 agents when used in patients with neuroendocrine tumors (NETs) based on current preclinical evidence, as well as current knowledge gaps that warrant future clinical investigation
What I don't like: It did not lessen the cystic pimple popping on my chin during my period unlike when I was taking another brand
Laboratories can use these aligned procurement characteristics to standardize how study arms are documented and repeated
Beyond 6 months: the long game You are either approaching your goal weight or maintaining a lower dose for continued management
Chang C-I, Low HP, Qiu L, Strohsnitter WC, Hsieh C-C
All four are types of semaglutide, which mimics the hormone released by the body when eating food, GLP-1